Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript

Yi Chen: Okay. Do you feel that customer orders from the Linea IVT platform could enable the company to demonstrate sequential growth in product and service revenue going forward?

Clay Shorrock: We do, and I think further to that end, we are hard at work at converting our customers that are currently only using our IVT templates over to the Linea IVT platform because the economics for us of that platform are much more compelling, as we talked about in the call, but also it’s a better platform for the customer. So to answer your question, the template economics can certainly make that happen, but the economics of the combined platform would be much more advantageous.

Yi Chen: Okay, last question. Could you provide an update on the cash position after September — the end of September?

Beth Jantzen: Sure. As I said a little early in the call, our cash position at November 30th is approximately $4.5 million.

Yi Chen: $4.5 million. Okay. Thank you.

Beth Jantzen: You’re welcome.

James Hayward: Thank you, Yi.

Operator: [Operator Instructions] As we have no further questions, this concludes our question-and-answer session. I would like to turn the conference back over to Dr. Hayward for any closing remarks.

James Hayward: Thank you very much, and thank you all for attending our call, and we look forward to keeping you updated on our progress as we move into this exciting period. And we wish you all happy holidays. Thank you.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may all now disconnect.